0QC9.L $52.68 -2.1834%
NBH $10.28 -0.1641%
VUZI $3.88 -3.1%
AVO.L $6.50 0%
VPC $20.33 0.1221%
0039.HK $0.15 -2.0134%
0621.HK $0.02 0%
QQQ $323.13 -0.9396%
1001.HK $0.42 0%
3073.HK $39.76 -0.6%
PSON.L $822.80 1.455%
4GBL.L $48.06 -2.9091%
0187.HK $2.72 -2.8571%
ANTIN.PA $14.81 1.0232%
PFMT $2.33 2.8761%
WYNN $105.05 -1.7353%
WXAG.L $11.84 3.09233%
DIS $91.39 -0.9966%
MCB $20.49 -4.9629%
RDFN $10.47 -5.6757%
FGBI $12.38 1.0612%
GVCIU $10.21 0%
AVXL $8.99 -2.2307%
YRD $2.30 -9.902%
0728.HK $4.27 -2.5114%
3838.HK $0.20 -1.0101%
TXG $52.12 -0.969%
DBEU $37.43 -0.0534%
ADPT $6.46 -4.9337%
MEI $40.71 0.0123%
VERX $20.05 1.519%
HCO.PA $4.98 -0.7968%
AMBP $3.54 -1.6667%
EL $196.48 -2.6314%
AC $36.88 0.5841%
2845.HK $102.55 -1.3942%
SOI.L $253.00 -1.5564%
0K8J.L $14.72 -2.2245%
JPBM.L $64.44 0.786%
HILS $0.42 -1.012%
ASPU $0.07 -7.5908%
VSL.L $79.40 1.2755%
0244.HK $0.24 5.1948%
FBIOP $18.66 0.1897%
FIG $23.80 -0.3141%
DWCR $27.98 0.1231%
0036.HK $0.09 0%
RDOG $34.62 0.3848%
RCSL3.SA $1.60 -4.1916%
BSMS $23.57 -0.106%
0LEF.L $90.46 -0.5526%
PPH.L $1 080.00 -1.3699%
ALAGP.PA $5.30 2.3166%
3963.HK $0.12 0%
ISUN.L $36.77 1.3508%
0418.HK $0.52 1.9608%
PWUPU $10.55 0.7641%
PCG-PA $22.08 0.4802%
BLRX $1.53 -7.2727%
RJI $8.11 0%
BGNE $237.85 -2.7617%
3639.HK $0.28 -5.1724%
FSMF.L $4.16 -0.4306%
ERESU $9.92 0%
0814.HK $0.59 -1.6667%
NRGW.L $402.48 0.3228%
AHHX $8.33 0%
0646.HK $0.53 -10.1695%
VSMV $39.07 -0.6105%
MIL.L $0.08 0%
FTSV.L $4.25 750%
LIQT $0.42 -1.1902%
FNDC $33.59 -0.5625%
DCPH $13.63 -0.8727%
DGSD.L $17.88 0.042%
LCWD.L $14.58 0.3787%
AFLG $23.81 0%
AGIO $25.37 -0.0591%
DKDCA $10.88 -0.0918%
PPIH $10.50 -2.3246%
PSEC-PA $14.96 -0.1335%
7230.HK $1.85 0%
BDRY $7.66 -5.3325%
SBET $2.78 -7.3333%
C6E.PA $110.40 0.7631%
PRFX $0.61 -0.1976%
OKYO $1.59 0.6329%
LFMDP $15.70 -0.2985%
FCCN.L $29.55 0%
DCNG $16.70 0%
SEDA $10.36 0.0966%
HIO $3.74 -0.2667%
MLUMG.PA $3.72 0%
1545.HK $0.09 -4.2105%
RF-PB $20.30 0.0986%
MNRL $32.50 0%
0UAN.L $15.40 1.1363%
HNGR $18.72 0%
0335.HK $0.66 0%
0SE5.L $95.04 -0.8872%
Eng
Логотип
Eng
Лого

Ocumension Therapeutics 1477.HK

$8.15

На 18:04, 12 мая 2023

Ключевые показатели

  • Marketcap

    5496121452.00000000

  • week52high

    14.80

  • week52low

    7.00

  • Revenue

    158957000

  • P/E TTM

    -11

  • Beta

    0.89418700

  • EPS

    -0.71000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    25 апр 2023 г. в 09:45

Описание компании

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. As of December 31, 2021, the company had 20 drug assets in its portfolio. Ocumension Therapeutics was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек